Tags |
|
|
Links |
|
|
Useful Advices - The Many Woes of an Online Giant
Overstock.com, with its very successful television campaign and terrific deals on wholesale merchandise of all kinds seems to be a model for the new online economy. The company has become something of a
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
darling in the online wholesale world but all is not well. However, Overstock.com has been troubled by shipping problems, legal struggles and an ongoing financial crisis. While the company enjoys an exce
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
llent reputation over all questions have been piling up.
A little over a year ago the Federal Trade Commission launched an investigation after receiving numerous complaints from customers regarding Over
A little over a year ago the Federal Trade Commission launched an investigation after receiving numerous complaints from customers regarding Over
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
tock’s shipping policies. At the time Overstock claimed that the increased complaints were a natural result of the dramatic increase in the number of orders they shipped and was not because of any illici
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
t behavior on their part.
On Tuesday, February 28 the Salt Lake City based company announced that it would be revising economic reports pertaining to the company all the way back to 2002. They claim tha
On Tuesday, February 28 the Salt Lake City based company announced that it would be revising economic reports pertaining to the company all the way back to 2002. They claim tha
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
t a long running error regarding freight costs has caused them overstate their economic loses during that period.
When all the recalculation is said and done it should increase Overstock’s inventory and
When all the recalculation is said and done it should increase Overstock’s inventory and
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
reduce its loses by $3.5 million. Overstock says they will re-file their reports with the Securities and Exchange Commission as soon as they can. Investors seemed to regard the revision as bad news and t
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
he company’s stock dropped 53 cents a share. This adds on to an overall drop in the stock of 18% for the year. In fact the present value of Overstock’s shares is less than one half of their all time high
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
that approached $60 a share.
Early in February the company released annual financial data that showed that the company had a net loss of $25 million despite increased earnings. So while the regained $3
Early in February the company released annual financial data that showed that the company had a net loss of $25 million despite increased earnings. So while the regained $3
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
5 million might seem like good news it will have little effect on the company’s expanding economic problems.
In August of last year Overstock’s former chairman, Patrick Byrne filed suit in California ag
In August of last year Overstock’s former chairman, Patrick Byrne filed suit in California ag
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ainst Rocker Partners and Gradient Analytics accusing the investment fund businesses of conspiracy. Byrne has claimed that the financial analyst purposely tried to drive down Overstock’s value by making
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
erroneous, if not fraudulent, statements on MSNBC and other financial news outlets with the intention of reaping ill-gotten personal profits for themselves and their hedge fund partners. However, many sa
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
that Overstock’s depressed stock value is their own fault for posting disappointing earnings and failure to provide a real business model.
Patrick Byrne’s struggle with enemies, either real or imagined
Patrick Byrne’s struggle with enemies, either real or imagined
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
, has undermined confidence in the company. Byrne has been accused of trying to draw attention from Overstock’s disappointing financial performance. Lending credibility to those who believe Byrne has com
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
e unhinged is his very public debate with Dallas Maverick’s owner Mark Cuban who he called a miscreant as well as other less prosaic adjectives.
While none of these issues are of immediate concern for c
While none of these issues are of immediate concern for c
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
stomers of Overstock and the company certainly isn’t about to fail anytime soon, it is somewhat alarming to know that they’ve been operating this long with out proper accounting controls over so vital ap
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
art of their business as shipping. If they are so slipshod as to not notice $3.5 million in discrepancies for four years there may well be other areas where Overstock’s overseers aren’t doing too good a
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
job as well.
If the company’s problems, particularly regarding earnings, continue there may well be changes to the way they do business. These changes are almost certain to affect Overstock’s wholesale
If the company’s problems, particularly regarding earnings, continue there may well be changes to the way they do business. These changes are almost certain to affect Overstock’s wholesale
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ustomers first. Companies make changes where the money is and at Overstock the majority of their money comes from customers buying in bulk for resell.
Investors will demand change in the company’s metho
Investors will demand change in the company’s metho
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ds eventually. If an Overstock customer is depending on the company’s present economic structure for the survival of their own business they’d better pay close attention to Overstock’s evolving condition
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefuladvices.org.ua/article/3681/usefuladvices-The-Many-Woes-of-an-Online-Giant.html">The Many Woes of an Online Giant</a>
BB link (for phorums):
[url=http://www.usefuladvices.org.ua/article/3681/usefuladvices-The-Many-Woes-of-an-Online-Giant.html]The Many Woes of an Online Giant[/url]
Related Articles:
Bookmark it:
|